Parallel Advisors, LLC Capricor Therapeutics, Inc. Transaction History
Parallel Advisors, LLC
- $4.34 Billion
- Q4 2024
A detailed history of Parallel Advisors, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 13 shares of CAPR stock, worth $183. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13Holding current value
$183% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
104Shares Held
8.41MCall Options Held
1.79MPut Options Held
1.4M-
Black Rock Inc. New York, NY1.63MShares$22.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$22.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA638KShares$8.99 Million0.0% of portfolio
-
State Street Corp Boston, MA512KShares$7.22 Million0.0% of portfolio
-
Superstring Capital Management LP New York, NY337KShares$4.75 Million4.49% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $343M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...